TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised, Double-blind, Parallel-group, Placebo-controlled, Duloxetine-referenced, Fixed-dose Study Evaluating the Efficacy and Safety of Lu AA21004 (15 and 20 mg/Day) in the Acute Treatment of Adult Patients With Major Depressive Disorder
Brief Summary: The purpose of the study is to evaluate the efficacy, tolerability and the safety of two fixed doses of vortioxetine in the treatment of major depressive disorder.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Vortioxetine: 15 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine (Lu AA21004) | Arm Label: Vortioxetine: 20 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine (Lu AA21004) | Arm Label: Duloxetine: 60 mg; Type: OTHER; Interventions: Drug: Duloxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Vortioxetine (Lu AA21004); Assigned to Arm(s): Vortioxetine: 15 mg, Vortioxetine: 20 mg | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine: 60 mg
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Vortioxetine 10 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine | Arm Label: Vortioxetine 20 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine | Intervention Type: DRUG; Name: Vortioxetine; Assigned to Arm(s): Vortioxetine 10 mg, Vortioxetine 20 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Vortioxetine 10 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine | Arm Label: Vortioxetine 15 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine | Intervention Type: DRUG; Name: Vortioxetine; Assigned to Arm(s): Vortioxetine 10 mg, Vortioxetine 15 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Vortioxetine (Lu AA21004); Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine (Lu AA21004) | Arm Label: Venlafaxine extended release; Type: ACTIVE_COMPARATOR; Interventions: Drug: Venlafaxine extended release | Intervention Type: DRUG; Name: Vortioxetine (Lu AA21004); Assigned to Arm(s): Vortioxetine (Lu AA21004) | Intervention Type: DRUG; Name: Venlafaxine extended release; Assigned to Arm(s): Venlafaxine extended release

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of Patient Navigation to Increase Colorectal Cancer Screening Rates Among Community Health Center Patients
Brief Summary: This study will investigate whether patient navigation can increase rates of colorectal cancer screening among linguistically and culturally diverse disadvantaged patients served by urban community health centers.


Options:
A: Intervention Type: BEHAVIORAL; Name: health education; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Expanded Chronic Care Model | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Expanded Chronic Care Model; Assigned to Arm(s): 1
C: Arm Label: Use of a Patient Navigator; Type: EXPERIMENTAL; Interventions: Other: Patient navigation | Arm Label: Usual Care; Type: OTHER; Interventions: Other: Usual care | Intervention Type: OTHER; Name: Patient navigation; Assigned to Arm(s): Use of a Patient Navigator | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual Care
D: Intervention Type: BEHAVIORAL; Name: Motivational Interview with care plan and education; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial on Falls and Malnutrition Prevention in the Community in 85 Year Old Subjects
Brief Summary: Objective: To determine the effectiveness of an individual multifactorial intervention on falls and undernutrition risk in very older people in the community.


Options:
A: Arm Label: usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Arm Label: Multifactorial Falls Prevention Program; Type: EXPERIMENTAL; Interventions: Other: On-site exercise, Other: home-based exercise, Other: Educational and behavioural, Other: Management of modifiable risk factors | Intervention Type: OTHER; Name: On-site exercise; Assigned to Arm(s): Multifactorial Falls Prevention Program | Intervention Type: OTHER; Name: home-based exercise; Assigned to Arm(s): Multifactorial Falls Prevention Program | Intervention Type: OTHER; Name: Educational and behavioural; Assigned to Arm(s): Multifactorial Falls Prevention Program | Intervention Type: OTHER; Name: Management of modifiable risk factors; Assigned to Arm(s): Multifactorial Falls Prevention Program | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): usual care
B: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Other: Interdisciplinary intervention program | Intervention Type: OTHER; Name: Interdisciplinary intervention program; Assigned to Arm(s): Experimental group
C: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Other: physical therapy | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: physical therapy; Assigned to Arm(s): Intervention Group
D: Arm Label: nutritional and physical rehabilitation plan; Type: EXPERIMENTAL; Interventions: Behavioral: nutritional and a rehabilitation plan. | Intervention Type: BEHAVIORAL; Name: nutritional and a rehabilitation plan.; Assigned to Arm(s): nutritional and physical rehabilitation plan

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Inpatient Initiated Varenicline Tartrate for Smoking Cessation, for Smoking Related Illnesses.
Brief Summary: The Smoking Termination Opportunity for inPatients, (STOP) project is designed to capture the opportunity that is provided by admission for acute smoking related illness, to assist patients through withdrawal by use of a combination of:

* the new medication Champix with
* best practice counselling
* initiated in an inpatient setting

to achieve:

* sustained smoking abstinence
* reduced hospital bed and health service utilisation
* reduced inpatient smoking and craving prior to discharge


Options:
A: Arm Label: group A; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: group B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline, Drug: placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): group A, group B | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): group B
B: Arm Label: Champix plus counselling; Type: EXPERIMENTAL; Interventions: Drug: Champix | Arm Label: counselling alone; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Counselling alone | Intervention Type: DRUG; Name: Champix; Assigned to Arm(s): Champix plus counselling | Intervention Type: BEHAVIORAL; Name: Counselling alone; Assigned to Arm(s): counselling alone
C: Arm Label: Varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline | Arm Label: Sugar Pill or Placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sugar pill or Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Sugar pill or Placebo; Assigned to Arm(s): Sugar Pill or Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Inpatient Initiated Varenicline Tartrate for Smoking Cessation, for Smoking Related Illnesses.
Brief Summary: The Smoking Termination Opportunity for inPatients, (STOP) project is designed to capture the opportunity that is provided by admission for acute smoking related illness, to assist patients through withdrawal by use of a combination of:

* the new medication Champix with
* best practice counselling
* initiated in an inpatient setting

to achieve:

* sustained smoking abstinence
* reduced hospital bed and health service utilisation
* reduced inpatient smoking and craving prior to discharge


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Dose adjustment of nicotine replacement therapies | Arm Label: 2; Type: OTHER; Interventions: Drug: nicotine patch | Intervention Type: PROCEDURE; Name: Dose adjustment of nicotine replacement therapies; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: nicotine patch; Assigned to Arm(s): 2
B: Arm Label: QualiCCare education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: active comparator, QualiCCare education | Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: active comparator, QualiCCare education; Assigned to Arm(s): QualiCCare education
C: Arm Label: Champix plus counselling; Type: EXPERIMENTAL; Interventions: Drug: Champix | Arm Label: counselling alone; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Counselling alone | Intervention Type: DRUG; Name: Champix; Assigned to Arm(s): Champix plus counselling | Intervention Type: BEHAVIORAL; Name: Counselling alone; Assigned to Arm(s): counselling alone
D: Arm Label: 1 Nix Individual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Nix Individual | Arm Label: 2 Fimpa dig fri; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Fimpa dig fri | Intervention Type: BEHAVIORAL; Name: Nix Individual; Assigned to Arm(s): 1 Nix Individual | Intervention Type: BEHAVIORAL; Name: Fimpa dig fri; Assigned to Arm(s): 2 Fimpa dig fri

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Inpatient Initiated Varenicline Tartrate for Smoking Cessation, for Smoking Related Illnesses.
Brief Summary: The Smoking Termination Opportunity for inPatients, (STOP) project is designed to capture the opportunity that is provided by admission for acute smoking related illness, to assist patients through withdrawal by use of a combination of:

* the new medication Champix with
* best practice counselling
* initiated in an inpatient setting

to achieve:

* sustained smoking abstinence
* reduced hospital bed and health service utilisation
* reduced inpatient smoking and craving prior to discharge


Options:
A: Arm Label: Effectiveness of Nicotine patch only; Type: EXPERIMENTAL; Interventions: Drug: Nicotine Patch | Arm Label: Effectiveness of Combination NRT; Type: EXPERIMENTAL; Interventions: Drug: Nicotine lozenge, Drug: Nicotine Patch | Arm Label: Effectiveness of Varenicline [Chantix]; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Effectiveness of Varenicline [Chantix] | Intervention Type: DRUG; Name: Nicotine lozenge; Assigned to Arm(s): Effectiveness of Combination NRT | Intervention Type: DRUG; Name: Nicotine Patch; Assigned to Arm(s): Effectiveness of Combination NRT, Effectiveness of Nicotine patch only
B: Arm Label: Champix plus counselling; Type: EXPERIMENTAL; Interventions: Drug: Champix | Arm Label: counselling alone; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Counselling alone | Intervention Type: DRUG; Name: Champix; Assigned to Arm(s): Champix plus counselling | Intervention Type: BEHAVIORAL; Name: Counselling alone; Assigned to Arm(s): counselling alone
C: Intervention Type: DRUG; Name: varenicline (CP-526,555); Assigned to Arm(s): N/A
D: Arm Label: Varenicline and Placebo Patch; Type: PLACEBO_COMPARATOR; Interventions: Drug: Varenicline and Placebo Patch | Arm Label: Varenicline and Nicotine Patch; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline, Nicotine Patch | Intervention Type: DRUG; Name: Varenicline, Nicotine Patch; Assigned to Arm(s): Varenicline and Nicotine Patch | Intervention Type: DRUG; Name: Varenicline and Placebo Patch; Assigned to Arm(s): Varenicline and Placebo Patch

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trazodone for the Treatment of Sleep Disorders in Alzheimer's Disease: a Randomised, Double-blind, Placebo-controlled Study
Brief Summary: The purpose of this study is to determine whether trazodone is effective in the treatment of sleep disorders in Alzheimer's disease (AD).


Options:
A: Arm Label: Treatment Group; Type: EXPERIMENTAL; Interventions: Device: GammaSense Stimulation System (Active Settings) | Arm Label: Control Group; Type: SHAM_COMPARATOR; Interventions: Device: GammaSense Stimulation System (Sham Settings) | Intervention Type: DEVICE; Name: GammaSense Stimulation System (Active Settings); Assigned to Arm(s): Treatment Group | Intervention Type: DEVICE; Name: GammaSense Stimulation System (Sham Settings); Assigned to Arm(s): Control Group
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control Condition | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Individualized Social Activities (ISA) | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physical Resistance Training and Walking (PRT/walking) | Arm Label: 4; Type: EXPERIMENTAL; Interventions: Behavioral: Combined ISA/PRT/walking | Intervention Type: BEHAVIORAL; Name: Control Condition; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Individualized Social Activities (ISA); Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Physical Resistance Training and Walking (PRT/walking); Assigned to Arm(s): 3 | Intervention Type: BEHAVIORAL; Name: Combined ISA/PRT/walking; Assigned to Arm(s): 4
C: Arm Label: Trazodone; Type: EXPERIMENTAL; Interventions: Drug: Trazodone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Trazodone; Assigned to Arm(s): Trazodone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Timed Activity Intervention Protocol; Type: EXPERIMENTAL; Interventions: Behavioral: Timed Activity Intervention | Arm Label: Attention-Control Condition; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention-Control Condition | Intervention Type: BEHAVIORAL; Name: Attention-Control Condition; Assigned to Arm(s): Attention-Control Condition | Intervention Type: BEHAVIORAL; Name: Timed Activity Intervention; Assigned to Arm(s): Timed Activity Intervention Protocol

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trazodone for the Treatment of Sleep Disorders in Alzheimer's Disease: a Randomised, Double-blind, Placebo-controlled Study
Brief Summary: The purpose of this study is to determine whether trazodone is effective in the treatment of sleep disorders in Alzheimer's disease (AD).


Options:
A: Arm Label: Suvorexant; Type: EXPERIMENTAL; Interventions: Drug: Suvorexant, Drug: Dose-matched Placebo to Suvorexant | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Dose-matched Placebo to Suvorexant | Intervention Type: DRUG; Name: Suvorexant; Assigned to Arm(s): Suvorexant | Intervention Type: DRUG; Name: Dose-matched Placebo to Suvorexant; Assigned to Arm(s): Placebo, Suvorexant
B: Arm Label: Suvorexant HD; Type: EXPERIMENTAL; Interventions: Drug: Suvorexant High Dose (HD) | Arm Label: Suvorexant LD; Type: EXPERIMENTAL; Interventions: Drug: Suvorexant Low Dose (LD) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Comparator: Placebo | Intervention Type: DRUG; Name: Suvorexant High Dose (HD); Assigned to Arm(s): Suvorexant HD | Intervention Type: DRUG; Name: Suvorexant Low Dose (LD); Assigned to Arm(s): Suvorexant LD | Intervention Type: DRUG; Name: Comparator: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Trazodone; Type: EXPERIMENTAL; Interventions: Drug: Trazodone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Trazodone; Assigned to Arm(s): Trazodone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Suvorexant HD; Type: EXPERIMENTAL; Interventions: Drug: Suvorexant High Dose (HD) | Arm Label: Suvorexant LD; Type: EXPERIMENTAL; Interventions: Drug: Suvorexant Low Dose (LD) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Comparator: Placebo | Intervention Type: DRUG; Name: Suvorexant High Dose (HD); Assigned to Arm(s): Suvorexant HD | Intervention Type: DRUG; Name: Suvorexant Low Dose (LD); Assigned to Arm(s): Suvorexant LD | Intervention Type: DRUG; Name: Comparator: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Billroth-I and Roux-en-Y Reconstruction After Distal Subtotal Gastrectomy for Gastric Cancer Patients : Prospective Randomized Study
Brief Summary: The purpose of this trial is to compare the degree of reflux, operative outcomes and quality of life between Roux en Y and Billroth-I reconstructions after distal subtotal gastrectomy for gastric cancer


Options:
A: Arm Label: Conventional Roux-en-Y anastomosis; Type: OTHER; Interventions: Procedure: Conventional Roux-en-Y Gastrojejunostomy | Arm Label: Uncut Roux-en-Y anastomosis; Type: EXPERIMENTAL; Interventions: Procedure: Uncut Roux-en-Y Gastrojejunostomy | Intervention Type: PROCEDURE; Name: Conventional Roux-en-Y Gastrojejunostomy; Assigned to Arm(s): Conventional Roux-en-Y anastomosis | Intervention Type: PROCEDURE; Name: Uncut Roux-en-Y Gastrojejunostomy; Assigned to Arm(s): Uncut Roux-en-Y anastomosis
B: Arm Label: Billroth-I; Type: EXPERIMENTAL; Interventions: Procedure: Billroth-I | Arm Label: Roux en Y; Type: EXPERIMENTAL; Interventions: Procedure: Roux en Y | Intervention Type: PROCEDURE; Name: Billroth-I; Assigned to Arm(s): Billroth-I | Intervention Type: PROCEDURE; Name: Roux en Y; Assigned to Arm(s): Roux en Y
C: Arm Label: modified BII+Braun; Type: ACTIVE_COMPARATOR; Interventions: Procedure: modified BII+Braun | Arm Label: traditional BII+Braun; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: modified BII+Braun; Assigned to Arm(s): modified BII+Braun
D: Arm Label: Roux-en Y; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Roux-en Y reconstruction | Arm Label: Billroth-I; Type: EXPERIMENTAL; Interventions: Procedure: Billroth-I reconstruction | Intervention Type: PROCEDURE; Name: Roux-en Y reconstruction; Assigned to Arm(s): Roux-en Y | Intervention Type: PROCEDURE; Name: Billroth-I reconstruction; Assigned to Arm(s): Billroth-I

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cognitive Behavioral Therapy for Arthritis Pain and Insomnia in Older Adults
Brief Summary: This study compares the efficacy of three group interventions for people with co-morbid osteoarthritis (OA) and insomnia to help them manage their OA symptoms. The investigators hypothesize that a combination cognitive-behavioral treatment will produce significantly greater initial and long-term improvements in OA symptoms than will the other two treatments.


Options:
A: Arm Label: Cognitive Behavioral Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Mindfulness-Based Stress Reduction; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mindfulness Based Stress Reduction | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): Cognitive Behavioral Therapy | Intervention Type: BEHAVIORAL; Name: Mindfulness Based Stress Reduction; Assigned to Arm(s): Mindfulness-Based Stress Reduction
B: Arm Label: A Exposure long; Type: EXPERIMENTAL; Interventions: Behavioral: Exposure in vivo | Arm Label: B Exposure short; Type: EXPERIMENTAL; Interventions: Behavioral: Exposure in vivo | Arm Label: C Cognitive behavioural psychotherapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioural Psychotherapy | Intervention Type: BEHAVIORAL; Name: Exposure in vivo; Assigned to Arm(s): A Exposure long, B Exposure short | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioural Psychotherapy; Assigned to Arm(s): C Cognitive behavioural psychotherapy
C: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: tailored cognitive behavior therapy, Behavioral: standard care | Intervention Type: BEHAVIORAL; Name: tailored cognitive behavior therapy; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: standard care; Assigned to Arm(s): Arm 1
D: Arm Label: Lifestyles A; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyles A | Arm Label: Lifestyle B; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyles B | Arm Label: Lifestyles C; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Lifestyles C | Intervention Type: BEHAVIORAL; Name: Lifestyles A; Assigned to Arm(s): Lifestyles A | Intervention Type: BEHAVIORAL; Name: Lifestyles B; Assigned to Arm(s): Lifestyle B | Intervention Type: BEHAVIORAL; Name: Lifestyles C; Assigned to Arm(s): Lifestyles C

Answer: D